Stocks – Canopy Growth, ArQule Rise in Premarket; Microsoft Edges Lower

This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEC430DK_M.jpg
© Reuters. © Reuters.

Investing.com — Stocks in focus in premarket trade on Monday, 9th December.

  • Marijuana products group Canopy Growth Corp (NYSE:) rose 5.9% after saying it has hired David Klein to be its new CEO. Klein is currently chief financial officer at brewer Constellation Brands (NYSE:), whose stock was unchanged on the news.
  • U.K. supermarket chain Tesco (OTC:) (LON:) rose 5.2% after confirming that it’s considering a sale of its remaining Asian businesses, estimated by analysts to be worth around $9 billion.
  • Microsoft (NASDAQ:) edged down 0.3% after a report that China is accelerating efforts to remove U.S. computers and software from government offices and public institutions.
  • Cancer drug maker Synthorx (NASDAQ:) rose some 170% after agreeing to be bought by French pharma giant Sanofi (NASDAQ:) for some $2.5 billion
  • ArQule (NASDAQ:), another oncology specialist, also more than doubled after agreeing to be bought by Merck & Co (NYSE:) for $2.7 billion.
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Add Comment